Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risedronate for Treatment of Sublesional Osteoporosis After Spinal Cord Injury

NCT00138866 is registered in ClinicalTrials.gov with Toronto Rehabilitation Institute as lead sponsor.

NCT NCT00138866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00138866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risedronate for Treatment of Sublesional Osteoporosis After Spinal Cord Injury
Lead sponsor
Toronto Rehabilitation Institute
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2004
Completion date
March 31, 2009
Enrollment
46 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis